2593-23-9 Usage
General Description
2,4-dichloro-N-hydroxybenzamide is a chemical compound with the formula C7H5Cl2NO2. It belongs to the class of aromatic amines and is derived from N-hydroxybenzamide. It is a crystalline solid that is white to light yellow in color and has a molecular weight of 206.03 g/mol. 2,4-dichloro-N-hydroxybenzamide is used as a herbicide and plant growth regulator, primarily in the agricultural industry. It functions by interfering with the plant's growth processes and is effective in controlling a wide range of weed species. However, it is important to handle this compound with care due to its potential toxicity and environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 2593-23-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,9 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2593-23:
(6*2)+(5*5)+(4*9)+(3*3)+(2*2)+(1*3)=89
89 % 10 = 9
So 2593-23-9 is a valid CAS Registry Number.
2593-23-9Relevant articles and documents
Benzohydroxamic acids as potent and selective anti-HCV agents
Kozlov, Maxim V.,Kleymenova, Alla A.,Romanova, Lyudmila I.,Konduktorov, Konstantin A.,Smirnova, Olga A.,Prasolov, Vladimir S.,Kochetkov, Sergey N.
supporting information, p. 5936 - 5940 (2013/10/22)
A diverse collection of 40 derivatives of benzohydroxamic acid (BHAs) of various structural groups were synthesized and tested against hepatitis C virus (HCV) in full-genome replicon assay. Some of these compounds demonstrated an exceptional activity, suppressing viral replication at sub-micromolar concentrations. The compounds were inactive against key viral enzymes NS3, and NS5B in vitro assays, suggesting host cell inhibition target(s). The testing results were consistent with metal coordination by the BHAs hydroxamic group in complex with a target(s). Remarkably, this class of compounds did not suppress poliomyelitis virus (PV) propagation in RD cells indicating a specific antiviral activity of BHAs against HCV.
